Description
Tesamorelin | Growth Hormone-Releasing Hormone Analog – Research Peptide
Tesamorelin is a synthetic 44-amino-acid analog of growth hormone-releasing hormone (GHRH), stabilized by an N-terminal trans-3-hexenoyl modification that increases resistance to enzymatic degradation relative to the native sequence.
Preclinical and in vitro studies have characterized its binding affinity at the GHRH receptor, the downstream cyclic AMP signaling associated with pulsatile growth hormone release, and its comparative stability against native GHRH in model systems.
Common research applications: somatotropic axis signaling, GHRH receptor binding assays, and peptide stability research.
Specifications
| Compound | Tesamorelin |
|---|---|
| Quantity | 5mg per vial |
| Purity | 99%+ (HPLC/MS) |
| Form | Lyophilized powder |
| Storage | Store lyophilized at minus 20 C, protect from light. |
Other Tesamorelin sizes: 10mg
Frequently Asked Questions
What is Tesamorelin?
Tesamorelin is a synthetic analog of the full 44-amino-acid growth hormone-releasing hormone sequence, stabilised by an N-terminal trans-3-hexenoyl group that resists DPP-4 cleavage.
What is Tesamorelin studied for?
Research applications include the GHRH receptor pathway, peptide stability against enzymatic degradation, somatotropic axis regulation and adipose tissue metabolism models. All work is laboratory research only.
What purity is Tesamorelin 5mg supplied at?
It is supplied as lyophilized powder at 99%+ purity, verified by independent HPLC and mass spectrometry testing.
Is Tesamorelin available in other sizes?
Yes. Tesamorelin is also available as Tesamorelin 10mg.
For Research Use Only
This material is intended strictly for laboratory and research purposes. It is not intended for human or veterinary use, diagnosis, treatment, or consumption. By purchasing, the buyer confirms they are a qualified researcher and agrees to handle this product in compliance with all applicable regulations.
Reviews
There are no reviews yet.